Industry

Life Sciences

Connected Wellness

Virtusa's Life Sciences Practice

Driving innovation and transformation across key life sciences segments

Virtusa’s life sciences practice helps companies navigate a landscape where the market and competition dynamics are in flux. Drug pricing pressure, the patent cliff, increasingly stringent regulations, growth into emerging markets, and a shift to outcomes-based payment structures are a new reality. 

To help companies stay ahead of the game, we implement innovative business models centered on delivering better patient outcomes at a lower cost. We drive this innovation by combining our deep life sciences experience with next-generation technological capabilities to build software solutions that help companies thrive in this new ecosystem.

 

Driven by patient-centered innovation

Assistive AI for medical imaging

Trusted partner for Fortune 500 medical device firms

IoT and connected care

Transformative digital technology solutions

Dramatically increase the success of your digital transformation. Whether, it is about developing complete new solutions or scaling existing processes and staff worldwide, Virtusa helps you reach your goals in today's most complex and fast moving use cases. 

View all solutions
vLife™ | Healthcare and Life Sciences Applications Marketplace

The life science industry has been a late adopter of most innovative technologies, despite the large R&D budgets. vLife‚ serves as a medium to bridge the gap among various stakeholders of the industry and accelerate innovation.
Healthy Patient Platform
Our customizable platform features rules-driven intelligent automation to guide Customer Service Representatives (CSRs) through each customer interaction. Build loyalty and improve outcomes with patient-centric capabilities at your fingertips.
electronic Patient Informed Consent (ePIC)
Virtusa‚ electronic Informed Patient Consent (eIPC) solution harnesses digital technologies such as DPA, AI, NLP, and data analytics to simplify the informed consent process flow.
Cognitive Pharmacovigilance (PV) Intake Solution
Based on Pega's process and decision-based technology, our cognitive pharmacovigilance intake solution leverages OCR, NLP, and AI to create a reusable adverse event case processing and product compliant environment.
SalesInsights360

SalesInsights360 addresses the new normal of combining the in-person interactions with health care professionals with remote interaction and omnichannel capabilities even in offline mode.
View all solutions

We bring together the skills and expertise life sciences firms need most to create and improve patient experiences

  • Industry Knowledge
    Understanding the unique requirements and touchpoints of the entire life sciences value chain
  • Key Technologies
    Deep knowledge of key technologies that are disrupting the industry and leveraging best practices for integrating with or replacing legacy applications
  • Proven Methodologies
    Applying key methodologies for use cases and requirements such as design thinking and agile technologies to provide high-value and cost-effective solutions
  • Innovation Lab
    Innovation Center of Excellence (CoE) to identify the use cases that appear most ready to take advantage of the disruption

 

Life Sciences

HITRUST CSF Certified

Virtusa is HITRUST CSF Certified for information security on the following platforms:  Active Directory, Endpoints, and Network Devices. The HITRUST CSF Certified status demonstrates that the organization’s application development, testing, production support, and infrastructure management services teams have met key regulations and industry-defined requirements and are appropriately managing risk.

Segments

Contract Research Organizations

Learn how the technology solutions Virtusa provides helps Contract Research Organizations (CROs) align their services to better support their customers.

Biotech and Pharma

Discover the solutions Virtusa provides to help pharmaceutical and biotechnology companies overcome the rising costs of delivering new products to patients.

Distribution

Learn how the digital transformation solutions Virtusa provides the Healthcare and Life Sciences industry can help you achieve your distribution objectives.

Medical Devices and Diagnostics

Learn more about the groundbreaking solutions Virtusa offers medical devices and diagnostics companies to help expand their digital transformation journey.
/
Trusted technology partners

Where Life Sciences leaders turn for digital transformation

Enabling the Life Sciences industry to drive competitive advantage through improved patient outcomes

success story

Virtusa enables BYOD initiative for over 35,000 contractors for top 5 pharmaceutical firm

Virtusa helps top five pharma company deploy BYOD initiative for over 35,000 contractors on with vDaaS

Learn more
success story

UTHealth, Virtusa, Cardinal Health, and AWS use AI and Machine Learning to Advance Medical Research

Amazon Web Services (AWS) and Virtusa were brought in to assist the IBRI and Fuse by Cardinal Health to provide the technical skills and infrastructure to assess and optimize a simulated electronic health records (EHRs) dataset

Learn more
success story

Virtusa Helped a Multinational Pharmaceutical Company Fast-track its Clinical Trials by 25% With Modernized Cloud Data Hubs

The client is a leading Fortune 500 pharmaceutical manufacturer. As with many life sciences organizations, the client's organization had incrementally built their legacy IT environment responding to ongoing business needs.

Learn more
success story

AWS-Based IoT Data Aggregation and Analytics Platform Adds Safety, Productivity, and Efficiency to the Users of the Modjoul SmartBelt

The Modjoul SmartBelt enhances worker safety and productivity with a mobile app and an intelligent workplace wearable using a cognitive IoT platform to provide a well-connected work environment.
Learn more
success story

How Machine Learning, Simulated Data, AWS, and Virtusa Brought Innovation to Diabetes Research at the IBRI

See how machine learning, simulated data, AWS, and Virtusa brought innovation to diabetes research at the the Indiana Bioscience Research Institute (IBRI).
Learn more

Our perspectives

Virtusa's technology and industry experts share knowledge on the grappling business and digital transformation challenges. Get key tips and insights to inspire new thinking, avoid pitfalls and drive tangible results.

White paper

Population-level prediction for type 2 diabetes simulated EMR data

This paper discusses the synthesis of high-fidelity population-level electronic medical record (EMR) data using Proxi,(a simulated population-level data generator) on vLife‚ (Virtusa's open innovation platform) to create prediction models around Type 2 Diabetes as defined by researchers in IBRI.
White paper

Unlock the power of simulated data to accelerate research

Using simulated data to overcome the challenges posed by real world data and testing the prediction accuracy of a machine learning model that was trained on a simulated EMR dataset.
Article

Leveraging the AWS cloud to accelerate the digital transformation of life sciences

Growth and development of the public cloud has been an emerging trend for over a decade now, led by AWS as the innovative first mover. The aggressive move from pure retailer to advanced technology provider resulted in a dominant leadership position for AWS in today's $132B public cloud market (IDC).
Article

Software quality and device recalls

The definition of medical device has expanded quite a bit in the past decade. Not only do wheelchairs, imaging equipment and pacemakers qualify as medical devices, but so do health monitoring apps and digital health trackers.
Article

FinTechs made personal wealth management easier: Can MedTechs do the same for personal health?

The financial meltdown of 2007 did away with the image of banks as safe havens for wealth. A joint coup between emerging technologies and FinTech innovators triggered a change in how wealth was managed. The idea that an alternative to conventional banking models could exist suddenly seemed viable.